Novartis India Ltd — Important, 29-07-2026: Company Update

Novartis India completed the sale of 17,450,680 equity shares from Novartis AG to a group led by ChrysCapital, signaling a significant ownership transition. The company's board approved an exclusive, royalty-free license for the "TEGRITAL" trademark, which will be assigned to them. Additionally, ownership of other key trademarks like Voveran and Macalvit was assigned royalty-free. Novartis India also secured an exclusive five-year distribution agreement for specific pharmaceutical products in India. A new leadership team was appointed, including Dr. Vikas Gupta as Managing Director and CEO, and Mr. Bhagwat Singh Deora as CFO, alongside several other senior management roles. The company launched a new website and adopted a new email domain, reflecting the new management.